InnoCare Pharma: Trading Debut, Valuation Scenario Analysis
InnoCare Pharma Ltd (9969 HK)Ā is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
439 Views
InnoCare (čÆŗčÆå„å) IPO Trading: At the Mercy of Retail Flipping
InnoCare, a China-based biotech company founded by a famous scientist, raised USD 270 million at HKD 8.95 per share. In this insight, we will cover...
628 Views
ECM Weekly (15 Mar 2020) - SBI Cards, SCG Package, Innocare, Akesobio, Zhenro Services
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Asia IPOs...
632 Views
InnoCare (čÆŗčÆå„å) IPO: Bifurcated Book, Update of Our View
InnoCare launched the book building on March 11th to raise up to USD 288 million to list in Hong Kong. Book building will end on March 16...
681 Views
InnoCare Pharma IPO: Valuation Easy to Swallow
InnoCare Pharma Ltd (9969 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
597 Views